ITC starts clinical trials of nasal spray for COVID-19 prevention

Developed by scientists at ITC Life Sciences and Technology Centre, the company plans to market it under the Savlon brand

ITC announces Rs 150 crore COVID-19 contingency fund

This fund will be utilised primarily to provide relief to the vulnerable and most needy sections of society

The segment’s Ebitda at Rs 688 crore in the last fiscal year, rose by 51 per cent year-on-year.

The company, said its expenses for the quarter fell about 39 per cent to Rs 63.14 billion.

SUUTI which owned 11.12 percent pared the stake via block deals in the market.